Prostate cancer Board decisions

The Board has remanded the case for additional development, including obtaining medical records and scheduling a VA genitourinary examination.

The Veteran's appeals for service connection were dismissed due to his death.

The Veteran's claim for an earlier effective date for service connection of prostate cancer residuals is denied as there was no prior claim filed before August 1, 2005.

The Veteran's bladder cancer is not service-connected due to lack of evidence showing it was caused by Agent Orange exposure or other events during his period of active service. The claim for prostate cancer was denied as there was no current diagnosis.

The Board denied the appellant's claims for an initial compensable evaluation for his right inguinal area scar disability and service connection for prostate cancer residuals, finding no basis for a compensable rating under the applicable regulations.

The Veteran's claim for an initial combined rating in excess of 40 percent for residuals of prostate cancer, to include voiding dysfunction, is being remanded due to the need for a VA genitourinary examination and additional development.

The Veteran's prostate cancer, low back disability, and right hip disability were not incurred or aggravated by his active service. The Board found no evidence linking these conditions to his military service.

The Veteran's appeal has been dismissed due to his death. The Board cannot proceed with the merits of these claims as he is no longer alive.

The Veteran's claim for an initial rating in excess of 60 percent for residuals of prostate cancer and a compensable rating for right testicle orchidynia was denied. The Board found that the evidence did not support ratings higher than the current 60 percent for both conditions.

The Board found that the appellant's post-operative residuals of prostate cancer are not proximately due to VA carelessness, negligence, or lack of proper skill. Therefore, compensation under 38 U.S.C.A. § 1151 is denied.

The Veteran's claims for service connection for various conditions, including visual disability, arthritis of the feet (gout), fractured ankles, prostate cancer, heart disability, and COPD, were denied as there is no competent medical evidence linking these conditions to his military service.

The Veteran's claim for service connection for prostate cancer, which is linked to Agent Orange exposure, has been remanded due to the lack of combat pay records and unit records showing temporary duty in Vietnam.

The Board has restored the Veteran's 100% disability rating for prostate cancer and granted service connection for erectile dysfunction. The effective date remains October 18, 2007.

The Veteran's appeal is remanded for further development, including a VA examination to determine the current severity of his prostate cancer residuals with erectile dysfunction and whether his urinary frequency complaints are related to his service-connected condition.

The Board has determined that the Veteran's prostate cancer is not related to service, including exposure to herbicides like Agent Orange.

The Board has determined that the Veteran's prostate cancer and diabetes mellitus, type II are service connected due to exposure to herbicide agents during his active duty in Vietnam.

The Veteran's bilateral hearing loss disability is attributable to in-service noise exposure and service connection is granted. The issue of prostate cancer will be remanded for further development.

The Veteran's claim for an initial evaluation in excess of 40 percent for service-connected residuals of prostate cancer, post-operative radical prostatectomy is being remanded due to the need for additional development.

The Board has determined that the reduction of the Veteran's disability rating from 100% to 40% and later to 60% was proper. The current evaluation for residuals of prostate cancer is found not to meet criteria warranting a higher than 60% rating.

The Veteran's prostate cancer is granted service connection based on presumed exposure to herbicides in Vietnam. The claim for lymphoma remains pending as the nature of the condition has not been definitively established.